Industry reports
Editor highlights

Pain Therapeutics Market and Forecasts, April 2014


 
1-4 of 4 reports for Pain Therapeutics

World Pain Management Therapeutics Industry Brief

  • Industry report
  • July 2013
  • 13 pages

... Financial overview 9.14.3 Product portfolio 9.14.4 Business strategies 9.14.5 Recent developments 9.15 pain therapeutics, inc. 9.15.1 Company overview 9 ...

The Indian Clinical Trial Market : Innovation and Technology Trends

  • Industry report
  • March 2012
  • 28 pages

... Astellas premier research shire prolexys duramed synta neurogesx auxilium az-seroquel novartis al pharma endoceutics pain therapeutic xanodyne az crestor poniard als (advance life science) pharmasset ...

Buprenorphine Market in The United States

  • Industry report
  • January 2012
  • 37 pages

... To nda submission bema buprenorphine Ideal fit for endo Complements endo S pain therapeutics portfolio providing an opportunity to offer hcps a Ladder Of pain products aligned with pain ...

Drug and Medication Sector Brief

  • Industry report
  • February 2012
  • 50 pages

... Area that is relatively new to genentech. Under its pain therapeutics discovery alliance with xenon, genentech has an exclusive license to compounds and a non-exclusive license to diagnostics ...



» Purchase Premium Reports (From $ 55 - $ 6 000)

45 reports for Pain Therapeutics
Hyperion Therapeutics Inc

Hyperion Therapeutics Inc

  • $ 55
  • Company report
  • April 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Hyperion Therapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

Enanta Pharmaceuticals Inc

April 2014 $ 55

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.